Yin H L, Kwiatkowski D J, Mole J E, Cole F S
J Biol Chem. 1984 Apr 25;259(8):5271-6.
Gelsolin is an actin-fragmenting cytoplasmic protein. A functionally similar protein has also been identified in plasma. We have compared the structure of the cytoplasmic and plasma forms of gelsolin and examined their biosynthetic relationships. Plasma gelsolin is larger than cytoplasmic gelsolin (Mr 93,000 versus 90,000, respectively) and is more positively charged. Partial amino acid sequencing analyses show that the two gelsolins share a common 29 amino acid sequence which lies at the NH2-terminal end of cytoplasmic gelsolin and spans residues 26-55 of plasma gelsolin. Compared with cytoplasmic gelsolin, plasma gelsolin contains an additional peptide of 25 amino acids at its NH2 terminus. The human hepatoma-derived cell line, HepG2, synthesizes both the 90-kDa and the 93-kDa gelsolins but secretes only the 93-kDa form. Pulse-chase experiments demonstrate that the rate of disappearance of the 93-kDa gelsolin from the cells corresponds with the rate of appearance of the 93-kDa gelsolin in the medium, whereas the rate of disappearance of the 90-kDa gelsolin is independent of and slower than that of the secreted plasma protein. We conclude that cytoplasmic and plasma gelsolins are structurally similar but not identical, that after synthesis these proteins are processed independently, and that the fate of each is distinct.
凝溶胶蛋白是一种可使肌动蛋白断裂的细胞质蛋白。在血浆中也鉴定出了一种功能相似的蛋白。我们比较了凝溶胶蛋白的细胞质形式和血浆形式的结构,并研究了它们的生物合成关系。血浆凝溶胶蛋白比细胞质凝溶胶蛋白大(分别为93,000道尔顿和90,000道尔顿),且带更多正电荷。部分氨基酸序列分析表明,这两种凝溶胶蛋白共有一个由29个氨基酸组成的共同序列,该序列位于细胞质凝溶胶蛋白的NH2末端,跨越血浆凝溶胶蛋白的26 - 55位残基。与细胞质凝溶胶蛋白相比,血浆凝溶胶蛋白在其NH2末端含有一个额外的25个氨基酸的肽段。人肝癌衍生细胞系HepG2可合成90 kDa和93 kDa的凝溶胶蛋白,但仅分泌93 kDa的形式。脉冲追踪实验表明,93 kDa凝溶胶蛋白从细胞中消失的速率与93 kDa凝溶胶蛋白在培养基中出现的速率相对应,而90 kDa凝溶胶蛋白消失的速率与分泌的血浆蛋白无关且较慢。我们得出结论,细胞质凝溶胶蛋白和血浆凝溶胶蛋白在结构上相似但不相同,这些蛋白在合成后独立加工,且各自的命运不同。